Exclusive-Nvidia preparing Groq chips that can be sold in Chinese market, sources say

Nvidia is preparing a China-compatible variant of Groq inference chips after acquiring Groq in a $17 billion deal; the Groq chip is expected to be available in May. The work follows Nvidia restarting H200 production after obtaining U.S. export licenses and Chinese purchase orders, and the company plans to pair Groq chips with Vera Rubin chips (which cannot be sold in China) in new product lineups. This expands Nvidia's ability to address the Chinese inference market amid strong domestic competition (e.g., Baidu) and could meaningfully impact Nvidia's inference revenue opportunity.

Analysis

Nvidia’s move to create an adaptable inference offering for restricted markets is primarily an architectural play: decoupling inference silicon from an upstream training stack lowers integration friction and materially expands addressable endpoints (edge/cloud hybrids, telco, on-prem AI appliances). That strategy tends to grow unit volumes faster than ASPs, so the P&L impact will skew toward higher revenue run-rate with lower incremental gross margin versus training-focused sales.

Second-order beneficiaries include middleware and systems integrators who can now plug‑and‑play higher‑quality inference modules without reengineering entire stacks, and server OEMs that can monetize scale in cabinetry, power and cooling. Conversely, incumbent local inference-chip suppliers face accelerated product-cycle pressure, forcing either faster R&D or margin concession — expect pricing competition and subsidy-driven feature parity attempts within 6–18 months.

Key catalysts and risks are geopolitical and implementation: policy tightening (export controls, de‑facto embargoes) could compress the incremental market to near zero in days; conversely, smooth certification and partner integrations would show up in bookings within a fiscal quarter or two. Technical integration failures, driver/SDK mismatches, or Chinese vendor optimization around alternate ISAs are plausible reversal vectors over 3–24 months.

From a valuation perspective, this is optionality more than immediate cashflow — if the company captures even a few percent of an inference install base in restricted markets, revenue scales but margin mix shifts. Positioning should therefore prefer defined‑risk upside exposure to capture adoption while protecting against binary policy shocks and faster‑than-expected competitive erosion.

Key Decisions for Investors

• Long NVDA via a 12–18 month defined‑risk call spread (buy 12–18m OTM call, sell a further OTM call) to capture China/inference optionality while capping premium outlay; target 30–60% upside vs max loss = premium paid. Enter within 4–6 weeks to capture potential near‑term certification cadence.
• Hedge equity exposure: buy NVDA stock and purchase 9–12 month 15–20% OTM puts (protective puts) sized to cover 30–50% of position notional. This preserves upside from adoption while limiting tail loss from a sudden export‑control reversal; cost = put premium (~1–3% of notional typical).
• Relative trade — long NVDA / short BIDU (6–12 month horizon): size 0.6–0.8 NVDA exposure per 1.0 BIDU exposure to express hardware monetization vs local software/servicing margin squeeze. Target 10–20% relative outperformance; stop if NVDA underperforms by >15% absolute in 30 days (policy shock signal).
• If seeking yield, sell near‑term NVDA covered calls on existing holdings (4–8 week expiries) to harvest elevated implied volatility while retaining longer‑dated upside optionality. Keep strike >=10% OTM to avoid early assignment versus anticipated adoption newsflows.